A prospective study of the modified Atkins diet for adults with idiopathic generalized epilepsy

Epilepsy and Behavior

Volumn 53, Issue , 2015, Pages 197-201

  Kverneland, Magnhild ^a   Selmer, Kaja K ^b,c   Nakken, Karl O ^a   Iversen, Per O ^b,c   Taubøll, Erik ^a,c  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c UNIVERSITY OF OSLO   (Norway)

Author keywords

Adults; Generalized epilepsy; Ketogenic diet; Modified Atkins diet; Treatment

Indexed keywords

ANTICONVULSIVE AGENT; CLOBAZAM; ETHOSUXIMIDE; ETIRACETAM; LAMOTRIGINE; PHENOBARBITAL; PHENYTOIN; TOPIRAMATE; VALPROIC ACID; ZONISAMIDE;

ADJUVANT THERAPY; ADOLESCENT; ADULT; ARTICLE; CHILDHOOD ABSENCE EPILEPSY; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DIET THERAPY; DRUG TOLERABILITY; FEMALE; GENERALIZED EPILEPSY; HUMAN; IDIOPATHIC DISEASE; JEAVONS SYNDROME; MALE; MIDDLE AGED; MODIFIED ATKINS DIET; MOTIVATION; MYOCLONUS EPILEPSY; PATIENT COMPLIANCE; PROSPECTIVE STUDY; QUALITY OF LIFE; QUESTIONNAIRE; SEX DIFFERENCE; TREATMENT DURATION; TREATMENT RESPONSE; YOUNG ADULT; CLINICAL TRIAL; DRUG RESISTANT EPILEPSY; EPILEPSY, GENERALIZED; KETOGENIC DIET; LOW CARBOHYDRATE DIET; MULTIMODALITY CANCER THERAPY; PROCEDURES;

ADOLESCENT; ADULT; ANTICONVULSANTS; COMBINED MODALITY THERAPY; DIET, CARBOHYDRATE-RESTRICTED; DRUG RESISTANT EPILEPSY; EPILEPSY, GENERALIZED; FEMALE; HUMANS; KETOGENIC DIET; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; QUALITY OF LIFE; YOUNG ADULT;

EID: 84946828851     PISSN: 15255050     EISSN: 15255069     Source Type: Journal    
DOI: 10.1016/j.yebeh.2015.10.021     Document Type: Article

References (21)

1. Klein P., Tyrlikova I., Mathews G.C. Dietary treatment in adults with refractory epilepsy: a review. Neurology 2014, 83:6251-6263.
2. Ye F., Li X.J., Jiang W.L., Sun H.B., Liu J. Efficacy of and patient compliance with a ketogenic diet in adults with intractable epilepsy: a meta-analysis. J Clin Neurol 2015, 11:26-31.
3. Jallon P., Latour P. Epidemiology of idiopathic generalized epilepsies. Epilepsia 2005, 46(Suppl. 9):5.
4. Mohanraj R., Brodie M.J. Outcomes of newly diagnosed idiopathic generalized epilepsy syndromes in a non-pediatric setting. Acta Neurol Scand 2007, 115:204-208.
5. Felton E. The generalized epilepsies: description, pathophysiology, treatment, and prognosis. Neurol Rep 2015, 8:11-18.
6. Baykan B., Martinez-Juarez I.E., Altindag E.A., Camfield C.S., Camfield P.R. Lifetime prognosis of juvenile myoclonic epilepsy. Epilepsy Behav 2013, 28(Suppl. 1):S18-S24.
7. Kossoff E.H., Henry B.J., Cervenka M.C. Efficacy of dietary therapy for juvenile myoclonic epilepsy. Epilepsy Behav 2013, 26:162-164.
8. Berg A.T., Berkovic S.F., Brodie M.J., Buchhalter J., Cross J.H., van Emde Boas W., et al. Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology, 2005-2009. Epilepsia 2010, 51:676-685.
9. Stavem K., Bjornaes H., Lossius M.I. Reliability and validity of a Norwegian version of the quality of life in epilepsy inventory (QOLIE-89). Epilepsia 2000, 41(1):7.
10. Scott-Lennox J., Bryant-Comstock R., Lennox G.A., Baker G.A. Reliability, validity and responsiveness of a revised scoring system for the Liverpool Seizure Severity Scale. Epilepsy Res 2001, 44(1):11.
11. Kossoff E.H., Rowley H., Sinha S.R., Vining E.P. A prospective study of the modified Atkins diet for intractable epilepsy in adults. Epilepsia 2008, 49:316-319.
12. Wiebe S., Matijevic S., Eliasziw M., Derry P.A. Clinically important change in quality of life in epilepsy. J Neurol Neurosurg Psychiatry 2002, 73:116-120.
13. Iqbal N., Caswell H., Muir R., Cadden A., Ferguson S., Mackenzie H., et al. Neuropsychological profiles of patients with juvenile myoclonic epilepsy and their siblings: An extended study. Epilepsia 2015, 56:1301-1308.
14. Camfield C.S., Camfield P.R. Juvenile myoclonic epilepsy 25years after seizure onset: a population-based study. Neurology 2009, 73:1041-1045.
15. Waaler P.E., Blom B.H., Skeidsvoll H., Mykletun A. Prevalence, classification, and severity of epilepsy in children in western Norway. Epilepsia 2000, 41:802-810.
16. Jakobsen M.U., O'Reilly E.J., Heitmann B.L., Pereira M.A., Balter K., Fraser G.E., et al. Major types of dietary fat and risk of coronary heart disease: a pooled analysis of 11 cohort studies. Am J Clin Nutr 2009, 89:1425-1432.
17. Mozaffarian D., Micha R., Wallace S. Effects on coronary heart disease of increasing polyunsaturated fat in place of saturated fat: a systematic review and meta-analysis of randomized controlled trials. PLoS Med 2010, 7.
18. Groomes L.B., Pyzik P.L., Turner Z., Dorward J.L., Goode V.H., Kossoff E.H. Do patients with absence epilepsy respond to ketogenic diets?. J Child Neurol 2011, 26:160-165.
19. Nei M., Ngo L., Sirven J.I., Sperling M.R. Ketogenic diet in adolescents and adults with epilepsy. Seizure 2014, 23:439-442.
20. Thammongkol S., Vears D.F., Bicknell-Royle J., Nation J., Draffin K., Stewart K.G., et al. Efficacy of the ketogenic diet: which epilepsies respond?. Epilepsia 2012, 53:e55-e59.
21. Kverneland M., Tauboll E., Selmer K.K., Iversen P.O., Nakken K.O. Modified Atkins diet may reduce serum concentrations of antiepileptic drugs. Acta Neurol Scand 2015, 131:187-190.